These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2667312)

  • 21. [Hemodynamic effects of different antihypertensive combinations].
    Wiechmann HW
    Dtsch Med Wochenschr; 1988 Jun; 113(25):1007-12. PubMed ID: 3289874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil.
    Wacker J; Werner P; Walter-Sack I; Bastert G
    Nephrol Dial Transplant; 1998 Feb; 13(2):318-25. PubMed ID: 9509441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative central and peripheral antihypertensive mechanisms of urapidil and prazosin.
    Brody MJ; Webb RL; Mangiapane ML; Porter JP; Bonham AC; Trapani AJ
    Am J Med; 1984 Oct; 77(4A):74-80. PubMed ID: 6091451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved orthostatic dysregulation record after administration of a sustained-release form of urapidil.
    Kirsten R; Nelson K; Kirch W; Hutt HJ; Molz KH; Theodor R; Nieder M; Dilger C; Haerlin R; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):338-41. PubMed ID: 2777422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].
    Wacker J; Müller J; Grischke EM; Unkels R; Bastert G
    Zentralbl Gynakol; 1994; 116(5):271-3. PubMed ID: 8023622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency Room Treatment of Hypertensive Crises.
    Salkic S; Brkic S; Batic-Mujanovic O; Ljuca F; Karabasic A; Mustafic S
    Med Arch; 2015 Oct; 69(5):302-6. PubMed ID: 26622081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
    Yang W; Zhou YJ; Fu Y; Qin J; Qin S; Chen XM; Guo JC; Wang Z; Zhan H; Li J; He JY; Hua Q
    Yonsei Med J; 2017 Jan; 58(1):105-113. PubMed ID: 27873502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 29. Urapidil in the treatment of hypertension.
    Rosendorff C
    Drugs; 1988; 35 Suppl 6():188-92. PubMed ID: 3042358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies.
    Hirschl MM; Seidler D; Zeiner A; Wagner A; Heinz G; Sterz F; Laggner AN
    Am J Emerg Med; 1993 Nov; 11(6):653-6. PubMed ID: 8240575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies.
    Hirschl MM; Binder M; Bur A; Herkner H; Müllner M; Woisetschläger C; Laggner AN
    Intensive Care Med; 1997 Aug; 23(8):885-8. PubMed ID: 9310807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central and peripheral cardiovascular actions of urapidil in normotensive and Goldblatt hypertensive animals.
    Zeigler DW; Shebuski RJ; Zimmerman BG
    Am J Med; 1984 Oct; 77(4A):81-6. PubMed ID: 6486159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of sublingual nifedipine and intravenous urapidil for treatment of acute postoperative hypertension].
    Wang Z; Wang DF; Lou N
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):317-9. PubMed ID: 21354920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal transient respiratory depression after maternal urapidil infusion for hypertension.
    Vanhaesebrouck S; Hanssens M; Allegaert K
    Eur J Pediatr; 2009 Feb; 168(2):221-3. PubMed ID: 18461359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of increasing doses of urapidil in patients with hypertension.
    Culbertson VL; Bryant PJ; Cady WJ; Rubison RM; Piepho RW; Nies AS; Byyny RL
    Clin Pharmacol Ther; 1986 Jun; 39(6):690-6. PubMed ID: 3519043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative tolerability profile of hypertensive crisis treatments.
    Grossman E; Ironi AN; Messerli FH
    Drug Saf; 1998 Aug; 19(2):99-122. PubMed ID: 9704248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive emergencies].
    Hirschl MM; Seilder D; Zeiner A; Wagner A; Heinz G; Sterz F; Laggner AN
    Minerva Cardioangiol; 1994; 42(7-8):365-71. PubMed ID: 7970031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Langtry HD; Mammen GJ; Sorkin EM
    Drugs; 1989 Dec; 38(6):900-40. PubMed ID: 2693046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of urapidil during intraoperative rise of arterial blood pressure in patients operated under general anesthesia].
    Grabowska-Gaweł A; Porzych K; Grześk G
    Przegl Lek; 2005; 62(3):148-51. PubMed ID: 16171143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies.
    Woisetschläger C; Bur A; Vlcek M; Derhaschnig U; Laggner AN; Hirschl MM
    J Hum Hypertens; 2006 Sep; 20(9):707-9. PubMed ID: 16826189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.